{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360011143664533504.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1053/j.gastro.2012.02.007"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0016508512001722?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0016508512001722?httpAccept=text/plain"}}],"dc:title":[{"@value":"High Levels of Hepatitis B Surface Antigen Increase Risk of Hepatocellular Carcinoma in Patients With Low HBV Load"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380011143664533377","@type":"Researcher","foaf:name":[{"@value":"Tai–Chung Tseng"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011143664533509","@type":"Researcher","foaf:name":[{"@value":"Chun–Jen Liu"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011143664533507","@type":"Researcher","foaf:name":[{"@value":"Hung–Chih Yang"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011143664533505","@type":"Researcher","foaf:name":[{"@value":"Tung–Hung Su"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011143664533380","@type":"Researcher","foaf:name":[{"@value":"Chia–Chi Wang"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011143664533376","@type":"Researcher","foaf:name":[{"@value":"Chi–Ling Chen"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011143664533378","@type":"Researcher","foaf:name":[{"@value":"Stephanie Fang–Tzu Kuo"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011143664533379","@type":"Researcher","foaf:name":[{"@value":"Chen–Hua Liu"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011143664533504","@type":"Researcher","foaf:name":[{"@value":"Pei–Jer Chen"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011143664533508","@type":"Researcher","foaf:name":[{"@value":"Ding–Shinn Chen"}]},{"@id":"https://cir.nii.ac.jp/crid/1380011143664533506","@type":"Researcher","foaf:name":[{"@value":"Jia–Horng Kao"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00165085"}],"prism:publicationName":[{"@value":"Gastroenterology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2012-05","prism:volume":"142","prism:number":"5","prism:startingPage":"1140","prism:endingPage":"1149.e3"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0016508512001722?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0016508512001722?httpAccept=text/plain"}],"createdAt":"2012-02-11","modifiedAt":"2025-11-03","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002215482011904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004235525732352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Hepatitis B virus (HBV)‐infected patients with low hepatitis B surface antigen and high hepatitis B core‐related antigen titers have a high risk of HBV‐related hepatocellular carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168808127360","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Envelope Proteins of Hepatitis B Virus: Molecular Biology and Involvement in Carcinogenesis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168820559232","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Blood-Based Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma, Including the Viral Genome and Glycosylated Proteins"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168850745216","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Use of a Deep Learning Approach for the Sensitive Prediction of Hepatitis B Surface Antigen Levels in Inactive Carrier Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168879457536","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The association between hepatocarcinogenesis and intracellular alterations due to hepatitis B virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021390759108224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Hepatitis B surface antigen reduction is associated with hepatitis B core-specific CD8+ T cell quality"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285704788964864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Immunity against Hepatitis\n            <scp>B</scp>\n            Virus and\n            <scp>HBV</scp>\n            Vaccines"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285710756364160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Hepatitis B virus core‐related antigen levels predict progression to liver cirrhosis in hepatitis B carriers"}]},{"@id":"https://cir.nii.ac.jp/crid/1360286995454329216","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The antiviral effects of human microRNA miR‐302c‐3p against hepatitis B virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617625928576","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Geranylgeranylacetone decreases the production of hepatitis B virus‐related antigen by comprehensive downregulation of mRNA transcription activity"}]},{"@id":"https://cir.nii.ac.jp/crid/1360302865548261888","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Hepatitis B surface antigen glycan isomer is a predictor of the development of hepatocellular carcinoma during nucleoside/nucleotide analog therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565166783165952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Serum Levels of M2BPGi as Short-Term Predictors of Hepatocellular Carcinoma in Untreated Chronic Hepatitis B Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168116348928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"JSH Guidelines for the Management of Hepatitis B Virus Infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567183487183616","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Mutual antagonism between hepatitis B viral mRNA and host microRNA let-7"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232188278784","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Possible biological mechanisms of entecavir <i>versus</i> tenofovir disoproxil fumarate on reducing the risk of hepatocellular carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360580232420830080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Ivermectin Inhibits HBV Entry into the Nucleus by Suppressing KPNA2"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584339749273600","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Kinetics of HBcrAg and HBsAg using highly sensitive iTACT assays in chronic hepatitis B patients with HBsAg seroclearance"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584343749915776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Kinetics of serum O‐glycosylated M‐hepatitis B surface antigen with hepatocellular carcinoma history and nucleos(t)ide analogue therapy in hepatitis B patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588379379166848","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Circulating thrombospondin 2 as a predictor of hepatocellular carcinoma in hepatitis B patients undergoing nucleos(t)ide analog therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848656191275648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657189309056","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virus"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567500721664","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Sequential therapy from entecavir to tenofovir alafenamide <i>versus</i> continuous entecavir monotherapy for patients with chronic hepatitis B"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861707377081472","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effects of nucleos(t)ide analogs on hepatitis B surface antigen reduction with interferon‐lambda 3 induction in chronic hepatitis B patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865814740694272","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Efficient implementation of hepatitis B surface antigen confirmatory neutralization tests"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869855583754496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Improving ultrasound image classification accuracy of liver tumors using deep learning model with hepatitis virus infection information"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204792922624","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A case of HBsAg seroclearance by readministration of lamivudine and adefovir dipivoxil in patient with liver cirrhosis due to hepatitis B virus infection"},{"@language":"ja","@value":"B型肝硬変に対するラミブジン・アデホビル再投与によりHBs抗原陰性化を認めた1例"},{"@value":"症例報告 B型肝硬変に対するラミブジン・アデホビル再投与によりHBs抗原陰性化を認めた1例"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク Bガタ カンコウヘン ニ タイスル ラミブジン ・ アデホビル サイトウヨ ニ ヨリ HBs コウゲン インセイカ オ ミトメタ 1レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204794066688","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A follow-up survey of hepatitis virus carriers after notification of their infection in Okayama prefecture"},{"@value":"岡山県における肝炎ウイルス検診陽性者の医療機関受診等に関する追跡調査"},{"@language":"ja-Kana","@value":"オカヤマケン ニ オケル カンエン ウイルス ケンシン ヨウセイシャ ノ イリョウ キカン ジュシン トウ ニ カンスル ツイセキ チョウサ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206449628672","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"1）B型肝炎と肝発癌"},{"@language":"en","@value":"1) Hepatitis B Virus Infection and Hepatocellular Carcinoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1390002184888914176","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Analysis of hepatitis virus infections among outpatients on chronic hemodialysis"},{"@language":"ja","@value":"外来血液維持透析患者における肝炎ウイルス感染症の現状および対策について"},{"@language":"ja-Kana","@value":"ガイライ ケツエキ イジ トウセキ カンジャ ニ オケル カンエンウイルス カンセンショウ ノ ゲンジョウ オヨビ タイサク ニ ツイテ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390005667263489664","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Factors Associated with Hepatitis B Surface Antigen Kinetics and Responses in Pegylated Interferon Alpha-2a Monotherapy for Patients with Chronic Hepatitis B"}]},{"@id":"https://cir.nii.ac.jp/crid/1390006895523803776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Peg-IFNα-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-up"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679771619840","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Two cases of acute hepatitis due to hepatitis E virus that are indigenous to Kitakyushu: a case report"},{"@language":"ja","@value":"北九州に土着したE型肝炎ウイルス株による急性肝炎の2例"},{"@value":"B型肝炎治療ガイドライン(第1.1版)"},{"@language":"ja-Kana","@value":"Bガタ カンエン チリョウ ガイドライン(ダイ1.1ハン)"},{"@language":"ja-Kana","@value":"キタキュウシュウ ニ ドチャク シタ Eガタ カンエンウイルスカブ ニ ヨル キュウセイ カンエン ノ 2レイ"},{"@value":"Guidelines for the management of hepatitis B virus infection"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679772059264","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Comparison of each HBs antigen assay and it's clinical utility"},{"@language":"ja","@value":"HBs抗原の測定法と臨床的意義"},{"@language":"ja-Kana","@value":"HBs コウゲン ノ ソクテイホウ ト リンショウテキ イギ"},{"@value":"Comparison of each HBs antigen assay and it^|^apos;s clinical utility"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679772498432","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"肝発癌後にPeg-IFNα-2a投与によりHBs抗原陰性化；HBs抗体陽性化が得られたB型慢性肝炎の1例"},{"@language":"en","@value":"Chronic hepatitis B which converting to HBs antigen negativity and HBs antibody positivity during Peg-IFNα-2a treatment after surgery for hepatocellular carcinoma: a case report"},{"@value":"症例報告 肝発癌後にPeg-IFNα-2a投与によりHBs抗原陰性化 : HBs抗体陽性化が得られたB型慢性肝炎の1例"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク カンハツガン ゴ ニ Peg-IFNa-2a トウヨ ニ ヨリ HBs コウゲン インセイカ : HBs コウタイ ヨウセイカ ガ エラレタ Bガタ マンセイ カンエン ノ 1レイ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390865806744558592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Chronic Hepatitis B in Which HBs Antigen Seroclearance Was Induced by Pegpegylated-interferonα-2a after Hepatocellular Carcinoma Treatment with Nucleos(t)ide Analogues: A Five-year Follow-up"},{"@value":"A Case of Chronic Hepatitis B in which HBs Antigen Seroclearance was Induced by Pegpegylated-interferonα-2a after Hepatocellular Carcinoma Treatment with Nucleos(t)ide Analogues: A Five-year Follow-up"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1053/j.gastro.2012.02.007"},{"@type":"CROSSREF","@value":"10.1007/s12072-017-9799-9_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1111/hepr.13277_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.2957/kanzo.57.666_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.3390/v13061124_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.3390/ijms222011051_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.3390/jcm11020387_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1111/liv.15065_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.3389/fimmu.2023.1257113_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1111/jvh.13869_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1002/9780470015902.a0026254_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1111/jgh.13989_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.2957/kanzo.55.310_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1111/apt.15197_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.2957/kanzo.54.84_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.4009/jsdt.53.139_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1111/jgh.15394_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1111/hepr.14016_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.3643-24_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1038/s41598-017-14747-5_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1111/hepr.12269_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1038/srep23237_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1111/jgh.16178_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.3390/v14112468_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1002/jmv.29109_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1038/s41598-024-76532-5_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1007/s00535-016-1229-6_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.2957/kanzo.55.706_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.2957/kanzo.54.402_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1002/jgh3.12443_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1111/hepr.13768_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1016/j.jiac.2023.09.007_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1007/s10396-025-01528-1_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.1016/j.jconrel.2017.09.044_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.5783-20_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.2169/naika.104.1861_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.5432-20_references_DOI_DCbvmMAvSgvSmtlJOcY8KCg3pW4"}]}